The structural properties of full-length annexin A11

Front Mol Biosci. 2024 Mar 7:11:1347741. doi: 10.3389/fmolb.2024.1347741. eCollection 2024.

Abstract

Annexin A11 (ANXA11) is a calcium-dependent phospholipid-binding protein belonging to the annexin protein family and implicated in the neurodegenerative amyotrophic lateral sclerosis. Structurally, ANXA11 contains a conserved calcium-binding C-terminal domain common to all annexins and a putative intrinsically unfolded N-terminus specific for ANXA11. Little is known about the structure and functions of this region of the protein. By analogy with annexin A1, it was suggested that residues 38 to 59 within the ANXA11 N-terminus could form a helical region that would be involved in interactions. Interestingly, this region contains residues that, when mutated, may lead to clinical manifestations. In the present study, we have studied the structural features of the full-length protein with special attention to the N-terminal region using a combination of biophysical techniques which include nuclear magnetic resonance and small angle X-ray scattering. We show that the N-terminus is intrinsically disordered and that the overall features of the protein are not markedly affected by the presence of calcium. We also analyzed the 38-59 helix hypothesis using synthetic peptides spanning both the wild-type sequence and clinically relevant mutations. We show that the peptides have a remarkable character typical of a native helix and that mutations do not alter the behaviour suggesting that they are required for interactions rather than being structurally important. Our work paves the way to a more thorough understanding of the ANXA11 functions.

Keywords: NMR; amyotrophic lateral sclerosis; annexins; intrinsically unstructured regions; small angle X-ray scattering; structure.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. AP was recipient of Grants from the Dementia Research Initiative (RE1 3556) which is funded by the Medical Research Council, Alzheimer’s Society, and Alzheimer’s Research United Kingdom, and from ARUK (ARUK-PG2019B-020). ED acknowledges financial support from ESRF. This work was supported by the Francis Crick Institute through provision of access to the MRC Biomedical NMR Centre. The Francis Crick Institute receives its core funding from Cancer Research United Kingdom (FC001029), the United Kingdom Medical Research Council (FC001029), and the Wellcome Trust (FC001029).